Bottom line
What is EKGAX's expense ratio?
EKGAX's expense ratio is 1.41%, or about $141 a year on every $10,000 invested. That is more expensive than 82% of global stock funds we track (median 0.95%). This share class also charges a front-end sales load of up to 5.75%, taken from your investment when you buy.
Updated Jul 1, 2026
EKGAX fee table
| Net expense ratio | 1.41% |
|---|---|
| Gross expense ratio | 1.57% |
| Management fee | 0.95% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.62% |
| Fee waiver / reimbursement | -0.16% |
| Max front-end sales load | 5.75% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Jul 1, 2026
What EKGAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| EKGAX | $710 | $1,012 | $1,352 | $2,309 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.41% expense ratio costs roughly $75,400 in lost growth, versus about $52,800 for the median global stock fund (0.95%).